Buffington Mohr McNeal’s Amgen AMGN Stock Holding History

Buffington Mohr McNeal’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-364	Closed	-$69K	–	127
2019 Q1	$69K	Buy	+364	New	+$69.5K	0.02%	167

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Buffington Mohr McNeal's AMGN Position: Q2 2019 in Review

Buffington Mohr McNeal sold out of Amgen (AMGN) in Q2 2019, closing a stake of 364 shares — an estimated $69K sold.

Buffington Mohr McNeal first reported a position in AMGN in Q1 2019 and held it in 1 quarter. The position peaked at $69K in Q1 2019. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

Buffington Mohr McNeal reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
Buffington Mohr McNeal sold 364 Amgen shares in Q2 2019, an estimated $69K.
Buffington Mohr McNeal first reported a position in Amgen in Q1 2019 and held it in 1 quarter.
Buffington Mohr McNeal's Amgen position peaked at $69K in Q1 2019.
1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Buffington Mohr McNeal's 13F filing for Q2 2019, filed 31 Jul 2019.